05/02/2024
11:15 PM | Vaxxinity (Filer)
| Form EFFECT | |
04/30/2024
3:46 PM | Vaxxinity (Filer)
| Form S-8 POS | |
04/30/2024
3:35 PM | Vaxxinity (Filer)
| Form S-8 POS | |
04/29/2024
4:06 PM | Vaxxinity (Filer)
| Form 10-K/A | |
04/29/2024
3:46 PM | Vaxxinity (Filer)
| Form PRE 14C | |
03/27/2024
3:18 PM | Vaxxinity (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/15/2024
3:15 PM | Vaxxinity (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
01/30/2024
3:04 PM | Prime Movers Lab Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023
9:30 AM | Vaxxinity (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/30/2023
4:03 PM | Prime Movers Lab GP I LLC (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023
4:13 PM | Prime Movers Lab GP I LLC (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023
4:10 PM | Prime Movers Growth GP I LLC (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023
3:20 PM | Prime Movers Growth GP I LLC (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023
3:21 PM | Prime Movers Lab GP I LLC (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2023
6:53 AM | Vaxxinity (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/03/2023
3:31 PM | Paula Molina Rene (Reporting)
Vaxxinity (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2023
8:42 PM | Powchik Peter (Reporting)
Vaxxinity (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2023
8:40 PM | Ray Sumita (Reporting)
Vaxxinity (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/04/2023
3:33 PM | Prime Movers Lab GP I LLC (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/28/2023
3:15 PM | Vaxxinity (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/22/2023
3:12 PM | Prime Movers Growth GP I LLC (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/22/2023
3:16 PM | Prime Movers Lab GP I LLC (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/14/2023
4:10 PM | Covaxx PML SPV 3 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/14/2023
4:11 PM | COVAXX PML SPV 2 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/14/2023
4:14 PM | Covaxx PML SPV 1 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/14/2023
4:18 PM | Prime Movers Growth Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/14/2023
4:19 PM | Prime Movers Lab Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023
3:34 PM | Covaxx PML SPV 3 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023
3:24 PM | Covaxx PML SPV 1 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023
3:26 PM | Prime Movers Lab Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023
3:31 PM | COVAXX PML SPV 2 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023
3:18 PM | Prime Movers Growth Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2023
4:32 PM | Prime Movers Lab Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2023
4:00 PM | Covaxx PML SPV 3 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2023
4:01 PM | Prime Movers Growth Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2023
4:02 PM | Prime Movers Lab Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023
4:02 PM | Covaxx PML SPV 1 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023
4:12 PM | COVAXX PML SPV 2 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023
4:20 PM | Covaxx PML SPV 3 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023
3:52 PM | Prime Movers Growth Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023
3:42 PM | Prime Movers Lab Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Shocking: One AI startup's revenue could surge 4,735% (Ad) Shocking: One AI Startup's Revenue Could Surge 4,735%
While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner. Click here to discover the AI chip company |
09/08/2023
5:05 PM | Prime Movers Lab Fund I LP (Reporting)
Sloss Dakin (Reporting)
Vaxxinity (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
4:33 PM | Prime Movers Lab Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/08/2023
4:14 PM | Covaxx PML SPV 3 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/08/2023
4:23 PM | Prime Movers Growth Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/08/2023
3:50 PM | COVAXX PML SPV 2 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023
3:38 PM | Prime Movers Growth Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023
3:42 PM | Covaxx PML SPV 1 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023
3:26 PM | COVAXX PML SPV 2 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023
3:32 PM | Covaxx PML SPV 3 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023
3:20 PM | Prime Movers Lab Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2023
3:13 PM | COVAXX PML SPV 2 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2023
3:14 PM | Covaxx PML SPV 3 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2023
3:15 PM | Covaxx PML SPV 1 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2023
3:16 PM | Prime Movers Growth Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2023
3:18 PM | Prime Movers Lab Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2023
11:15 PM | Vaxxinity (Filer)
| Form EFFECT | |
08/09/2023
6:30 AM | Vaxxinity (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2023
6:31 AM | Vaxxinity (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/26/2023
5:31 PM | Powchik Peter (Reporting)
Vaxxinity (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
5:32 PM | Diamandis Peter (Reporting)
Vaxxinity (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
5:34 PM | TOLEDANO GABRIELLE B (Reporting)
Vaxxinity (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
5:35 PM | Eade Katherine A. (Reporting)
Vaxxinity (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
5:37 PM | Ogilvie Landon E (Reporting)
Vaxxinity (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
5:37 PM | Smith James Alan (Reporting)
Vaxxinity (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
5:39 PM | HORNIG GEORGE R (Reporting)
Vaxxinity (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
3:30 PM | Vaxxinity (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2023
6:00 AM | Vaxxinity (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
